Literature DB >> 18007677

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Lenie Dijkshoorn1, Alexandr Nemec, Harald Seifert.   

Abstract

Since the 1970s, the spread of multidrug-resistant (MDR) Acinetobacter strains among critically ill, hospitalized patients, and subsequent epidemics, have become an increasing cause of concern. Reports of community-acquired Acinetobacter infections have also increased over the past decade. A recent manifestation of MDR Acinetobacter that has attracted public attention is its association with infections in severely injured soldiers. Here, we present an overview of the current knowledge of the genus Acinetobacter, with the emphasis on the clinically most important species, Acinetobacter baumannii.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18007677     DOI: 10.1038/nrmicro1789

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  611 in total

1.  Variations of AbaR4-type resistance islands in Acinetobacter baumannii isolates from South Korea.

Authors:  Dae Hun Kim; Young Kyoung Park; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2012-06-05       Impact factor: 5.191

2.  Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection.

Authors:  Leonardo Sorci; Ian Blaby; Jessica De Ingeniis; Svetlana Gerdes; Nadia Raffaelli; Valérie de Crécy Lagard; Andrei Osterman
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

3.  In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.

Authors:  Paul G Higgins; Thamarai Schneiders; Axel Hamprecht; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

4.  A taxonomically unique Acinetobacter strain with proteolytic and hemolytic activities recovered from a patient with a soft tissue injury.

Authors:  Marisa Almuzara; German Matías Traglia; Lenka Krizova; Claudia Barberis; Sabrina Montaña; Romina Bakai; Alicia Tuduri; Carlos Vay; Alexandr Nemec; María Soledad Ramírez
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

5.  Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.

Authors:  Jason W Sahl; J Kristie Johnson; Anthony D Harris; Adam M Phillippy; William W Hsiao; Kerri A Thom; David A Rasko
Journal:  BMC Genomics       Date:  2011-06-04       Impact factor: 3.969

6.  Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.

Authors:  Mark D Adams; E Ricky Chan; Neil D Molyneaux; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

7.  Draft genome sequence of an Acinetobacter genomic species 3 strain harboring a bla(NDM-1) gene.

Authors:  Yong Chen; Yujun Cui; Fei Pu; Guoqin Jiang; Xiangna Zhao; Yanting Yuan; Wei Zhao; Dongfang Li; Hui Liu; Yin Li; Ting Liang; Li Xu; Yan Wang; Qing Song; Jiyong Yang; Long Liang; Ruifu Yang; Li Han; Yajun Song
Journal:  J Bacteriol       Date:  2012-01       Impact factor: 3.490

8.  Novel mechanism for fluoroquinolone resistance in Acinetobacter baumannii.

Authors:  Sunil D Saroj; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

9.  Attack of the clones.

Authors:  Susannah Baldry
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

10.  Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii.

Authors:  Guangtao Huang; Shuai Le; Yizhi Peng; Yan Zhao; Supeng Yin; Lin Zhang; Xinyue Yao; Yinling Tan; Ming Li; Fuquan Hu
Journal:  Curr Microbiol       Date:  2013-01-18       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.